StemBio provides specialized processing, quality control, and cryopreservation for human-derived cells and tissues. They enable clinical applications of cellular therapies and tissue grafts through cGMP-compliant production of stem cells, exosomes, and gene therapies.
Funding
Funding not disclosed
Founders
Product
Problem
The development and application of cellular therapies and tissue grafts are hindered by the complex processing, stringent quality control, and specialized cryopreservation required for human-derived cells and tissues. This complexity limits accessibility and scalability for clinical use.
Solution
StemBio operates as a biotechnology hub specializing in the processing and storage of human-derived cells and tissues for clinical applications. The company leverages advanced stem cell processing methodologies, rigorous quality control protocols, and sophisticated cryopreservation techniques to develop cellular therapies and tissue grafts. StemBio's offerings aim to facilitate regenerative medicine and gene therapy by providing reliable, high-quality biological products. Their integrated approach ensures that processed materials are ready for use and meet clinical standards.
Target Audience
StemBio serves clinicians, researchers, and healthcare providers in fields such as orthopedics, aesthetics, regenerative medicine, and urology, as well as veterinary professionals.
Features
- **StemBioCell:** Production and banking of cellular therapeutic products, including Mesenchymal Stem Cells (MSC), Hematopoietic Stem Cells (HSC), Immunotherapy products, Tissue Engineering cellular products, and Stromal cellular products.
- **ExoStem:** Development of exosome products derived from Mesenchymal Stem Cells.
- **StemCord:** Autologous and allogeneic cord blood banking services.
- **StemTissue:** Banking of human-derived tissue grafts.
- **StemGene:** Development of gene therapies and treatments.
- **StemRegen:** Services and devices for regenerative applications, including Adinizer (Mechanical Stromal Vascular Fraction) and PRP (Platelet-Rich Plasma).
- **StemAnima:** Cellular therapy products and tissue grafts specifically for veterinary applications, addressing conditions such as paralysis, kidney failure, autoimmune diseases, and allergies.
- **cGMP Standards:** Operations and production processes for cellular products adhere to current Good Manufacturing Practice (cGMP) standards.
- **Quality Assurance:** Comprehensive tracking and recording of all operational and production stages from raw tissue supply to final product delivery.